granisetron and Demyelinating Diseases

granisetron has been researched along with Demyelinating Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aminian, A; Dehpour, AR; Ghazi-Khansari, M; Hassanzadeh, G; Javadi, S; Kafami, L; Mehr, SE; Noorbakhsh, F; Rahimian, R	1

Other Studies

1 other study(ies) available for granisetron and Demyelinating Diseases

Article	Year
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis. Neuroscience, 2013, Sep-17, Volume: 248 Topics: Animals; Biguanides; Cell Proliferation; Demyelinating Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Granisetron; Indoles; Leukocytes, Mononuclear; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Spinal Cord; Spleen; Treatment Outcome; Tropisetron	2013

Article

Year

Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.

Neuroscience, 2013, Sep-17, Volume: 248

Topics: Animals; Biguanides; Cell Proliferation; Demyelinating Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Granisetron; Indoles; Leukocytes, Mononuclear; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Spinal Cord; Spleen; Treatment Outcome; Tropisetron

2013